What Makes Neurogen's Test for Alzheimer’s Disease Unique


Author: Elisabeth Thijssen, PhD

Published On: April 10, 2026


If you’ve started noticing subtle memory shifts or if you have a family history of cognitive issues, you’ve likely looked into tests for Alzheimer’s Disease.

And if we’re being honest, it can feel confusing fast.

Some tests happen in clinics. Others are done at home. Some focus on symptoms, while others look deeper at what’s happening in the brain. But not all of them give you the same level of clarity.

That’s where the real issue comes in. Many tests either leave out critical information or don’t fully explain what your results actually mean for you.

In this guide, we’ll walk you through what makes us different at Neurogen by comparing our at-home Alzheimer’s test to both traditional testing and other at-home options, so you can understand what truly matters for your brain health.

What Most Alzheimer’s Testing Looks Like Today

For many people, the traditional path to Alzheimer’s testing starts after significant symptoms of cognitive decline that interfere with daily life.

From there, the process often becomes a series of steps. You might begin with a primary care visit, move to a specialist, and eventually undergo imaging or cognitive testing.

In most cases, the traditional process includes:

  • Multiple appointments across different providers
  • Long wait times for imaging or specialist access
  • Limited insight into early-stage changes
  • Results that don’t always clearly guide next steps

While this approach can be thorough, it’s often complex and time-consuming, especially when you’re looking for clear answers.

How At-Home Tests for Alzheimer’s Disease Are Changing the Landscape

At-home testing has opened the door to something important: earlier, more accessible insight into your brain health.

Instead of waiting for appointments or referrals, you can collect a sample from home and begin understanding what’s happening inside your body sooner.

These tests look at biomarkers, or signals in your blood that can reflect changes associated with Alzheimer’s Disease. It’s a powerful shift toward prevention and early awareness.

But not all at-home tests focus on the right signals to help understand if you are at risk for Alzheimer’s.

Here’s where many at-home tests fall short:

  • Incomplete biomarker panels in relation to cognition
  • Key markers like p-tau are treated as optional add-ons
  • Limited or unclear interpretation of results
  • No direct access to neurological expertise

So while the format is more convenient, the experience and overall value you get can vary widely.

Neurogen vs. Traditional Testing: A Simpler, Proactive Approach to Alzheimer’s Detection

When we compare Neurogen to the traditional testing process, the difference starts with accessibility.

Instead of navigating multiple appointments and referrals, you can begin the process from home on your schedule and in your environment.

The next major difference is timing. Clinical Alzheimer’s testing can take weeks or even months, from initial appointments to referrals and follow-up results.

With Neurogen, the process is streamlined from start to finish, helping you get meaningful insight much faster without the delays of a multi-step clinical path.

With Neurogen, the process is designed to be:

  • Accessible from home
  • Faster and more streamlined
  • Focused on early insight, not just late-stage diagnosis
  • Built to guide next steps, not just deliver data

This shift gives you clarity without the stress of navigating a complex system.

Neurogen vs. Other At-Home Tests for Alzheimer’s Disease

Not all at-home tests for Alzheimer’s Disease offer the same level of insight.

While many provide a starting point, the depth of what they measure — and how they support you afterward — can vary widely.

At Neurogen, we focus on two areas that truly change the experience: the biomarkers we test for and the expertise behind your results.

Built-In P-tau217 Biomarker: Not an Add-On, but a Foundation

One of the most important biomarkers in Alzheimer’s research today is called p-tau217. In simple terms, it’s a protein in the blood that’s closely linked to changes associated with Alzheimer’s Disease.

What makes p-tau217 so valuable is its ability to reflect these changes early — often before symptoms significantly impact your daily routine.

However, many at-home tests treat p-tau217 as an optional add-on. That means you may need to pay more just to access one of the most critical pieces of information.

That often leads to situations like:

  • Additional costs for more complete results
  • Incomplete data from the initial test
  • Less confidence in what your results actually show

At Neurogen, we’ve taken a different approach. P-tau217 is built directly into our test, and not added on later.

That means you start with a more complete picture of your brain health from day one.

Neurologist Interpretation: Real Expertise When You Need It

One of the most common frustrations with at-home testing is what happens after you get your results.

Many companies offer “clinician-reviewed” reports, but that often means AI-generated reports with limited context or generalized explanations.

When it comes to something as important as your brain health, that can leave you with more questions than answers.

At Neurogen, we believe interpretation matters just as much as the test itself and that you shouldn’t have to interpret results on your own.

Instead of a list of test results and a new wellness plan, you get:

  • Insight from specialists who understand brain health deeply
  • Clear explanations of what your results mean from an actual neurologist
  • Guidance on what to do next
  • Support tailored to your situation

This process helps you understand your results with confidence and gives you a clear picture of the next steps you can take on your memory health journey.

Why These Differences Matter for Your Brain Health

At the end of the day, a test for Alzheimer’s Disease isn’t just about collecting data. It’s about what you can actually do with that information.

Selecting an at-home test designed specifically for Alzheimer’s Disease gives you:

  • Earlier visibility into potential changes
  • More confidence in your results
  • A clearer path forward
  • The ability to take action sooner

Neurogen’s memory health ecosystem was designed specifically with people like you in mind — someone who is noticing subtle changes in the way they remember things and doesn’t want to wait for answers.

Taking the Next Step in Understanding Alzheimer’s Risk

Understanding your risk for Alzheimer’s Disease helps you gain early access to answers you can actually use.

When your test includes meaningful biomarkers like p-tau217 and is backed by real neurological expertise, it gives you more than data. It gives you clarity, confidence, and a clearer path forward.

At Neurogen, we believe understanding your brain health should feel empowering, not overwhelming, so that you can take control of what comes next.

Learn More About Neurogen

Take control of your brain health with a test designed to give you real answers. With built-in p-tau insights and access to neurological expertise, you’ll have the clarity to understand what’s happening and what to do next.

Elisabeth Thijssen, PhD

Elisabeth Thijssen, PhD

Linkedin

Dr. Elisabeth Thijssen leads Neurogen’s scientific vision, uniting over a decade of expertise in neurodegenerative research and biomarker innovation. Her groundbreaking work on Alzheimer’s blood testing has redefined what’s possible in early disease detection. Holding a Cum Laude PhD in the Neurochemistry of Alzheimer’s Disease, along with advanced degrees in Pharmaceutical and Biomedical Sciences, Dr. Thijssen’s leadership ensures Neurogen’s mission remains grounded in both scientific excellence and human purpose. With experience spanning consulting, biotech, and academic research, she has driven transformative R&D and strategic partnerships that translate science into real-world impact.